Co-Diagnostics ( NASDAQ: CODX ) is scheduled to announce Q2 earnings results on Thursday, August 8th, after market close. The consensus EPS Estimate is -$0.34 (-9.
7% Y/Y) and the consensus Revenue Estimate is $0.38M (+90.0% Y/Y).
Over the last 1 year, CODX has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
More on Co-Diagnostics Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Co-Diagnostics Historical earnings data for Co-Diagnostics Financial information for Co-Diagnostics.
